Abstract
Loss of aggrecan from articular cartilage is an early and critical event in the pathogenesis of osteoarthritis (OA) and is enzymatically mediated by aggrecanase activity. Since the discovery of aggrecanase-1 (ADAMTS-4) and aggrecanase- 2 (ADAMTS-5), both members of the “a disintegrin and metalloproteinase with thrombospondin motif” family of proteinases, other members of the family have been reported to have aggrecanase activity, as currently defined, including ADAMTS-1, -8, -9, -15 and -16. Understanding whether these other ADAMTS members are in fact genuine in vivo aggrecanases will be important for the development of therapeutic agents that aim to block aggrecan degradation. The goal of this review is to look at the current definition of “aggrecanase activity”, and define its strengths, weaknesses and suitability for determining which ADAMTS, are aggrecanases that participate in aggrecan catabolism in OA. In addition, we propose a more comprehensive definition of aggrecanase activity, based on 6 criteria that encompass both biochemical and biological characteristics of the endogenous aggrecanase activity detected in vitro and in vivo. Finally, using these criteria, we propose which ADAMTSs should be classified as aggrecanases and therefore be considered as drug targets for the development of chondroprotective OA treatments.
Keywords: ADAMTS-4 gene, Chondroitin Sulfate, aggrecanases, siRNAs, metalloproteinases
Current Pharmaceutical Biotechnology
Title: Will the Real Aggrecanase(s) Step Up: Evaluating the Criteria that Define Aggrecanase Activity in Osteoarthritis
Volume: 9 Issue: 1
Author(s): M. D. Tortorella and A. M. Malfait
Affiliation:
Keywords: ADAMTS-4 gene, Chondroitin Sulfate, aggrecanases, siRNAs, metalloproteinases
Abstract: Loss of aggrecan from articular cartilage is an early and critical event in the pathogenesis of osteoarthritis (OA) and is enzymatically mediated by aggrecanase activity. Since the discovery of aggrecanase-1 (ADAMTS-4) and aggrecanase- 2 (ADAMTS-5), both members of the “a disintegrin and metalloproteinase with thrombospondin motif” family of proteinases, other members of the family have been reported to have aggrecanase activity, as currently defined, including ADAMTS-1, -8, -9, -15 and -16. Understanding whether these other ADAMTS members are in fact genuine in vivo aggrecanases will be important for the development of therapeutic agents that aim to block aggrecan degradation. The goal of this review is to look at the current definition of “aggrecanase activity”, and define its strengths, weaknesses and suitability for determining which ADAMTS, are aggrecanases that participate in aggrecan catabolism in OA. In addition, we propose a more comprehensive definition of aggrecanase activity, based on 6 criteria that encompass both biochemical and biological characteristics of the endogenous aggrecanase activity detected in vitro and in vivo. Finally, using these criteria, we propose which ADAMTSs should be classified as aggrecanases and therefore be considered as drug targets for the development of chondroprotective OA treatments.
Export Options
About this article
Cite this article as:
Tortorella D. M. and Malfait M. A., Will the Real Aggrecanase(s) Step Up: Evaluating the Criteria that Define Aggrecanase Activity in Osteoarthritis, Current Pharmaceutical Biotechnology 2008; 9 (1) . https://dx.doi.org/10.2174/138920108783497622
DOI https://dx.doi.org/10.2174/138920108783497622 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Harnessing CD36 to Rein in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Gene Expression Profiling in Rodent Models for Schizophrenia
Current Neuropharmacology Evaluation of Pleotropic Protective Activity of <i>Capparis spinose</i> Extract on Arthritis Rat Model
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Neuroinflammation and Ageing: Current Theories and an Overview of the Data
Reviews on Recent Clinical Trials Gene Therapy for Osteoinduction
Current Gene Therapy Thyroid Ultrasound and Other Imaging Procedures in the Pediatric Age
Current Pediatric Reviews A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein
Current Drug Discovery Technologies Bisphosphonate Anticancer Activity in Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Neurokinin-1 (NK<sub>1</sub>) receptor antagonists as possible therapeutics for psychostimulant use disorders
CNS & Neurological Disorders - Drug Targets Oxidative Stress Biology and Cell Injury During Type 1 and Type 2 Diabetes Mellitus
Current Neurovascular Research Idronoxil as an Anticancer Agent: Activity and Mechanisms
Current Cancer Drug Targets The Immune System in Cancer Prevention, Development and Therapy
Anti-Cancer Agents in Medicinal Chemistry Effects of <i>Piper sarmentosum</i> on Bone Health and Fracture Healing: A Scoping Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Benzo[a]pyrene Toxicity and Inflammatory Disease
Current Rheumatology Reviews Revisiting the Antiviral Efficacy of Terpenoids: Plausible Adjunct Therapeutics for Novel SARS-CoV-2?
Endocrine, Metabolic & Immune Disorders - Drug Targets Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development in Mice
Current Cancer Drug Targets Type 2 Diabetes, Insulin Secretion and β-Cell Mass
Current Molecular Medicine The Trinity of Matrix Metalloproteinases, Inflammation, and Cancer: A Literature Review of Recent Updates
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Fluorescent SNAP-Tag Galectin Fusion Proteins as Novel Tools in Glycobiology
Current Pharmaceutical Design Adenosine and Inflammation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)